Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
269.7 USD | +0.11% | +0.35% | -6.31% |
05:03pm | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
03:38pm | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
Financials (USD)
Sales 2024 * | 32.95B | Sales 2025 * | 34.14B | Capitalization | 144B |
---|---|---|---|---|---|
Net income 2024 * | 6.12B | Net income 2025 * | 7.56B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 46.47B | Net Debt 2025 * | 40.28B | EV / Sales 2025 * | 5.41 x |
P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
18.1
x | Employees | 26,700 |
Yield 2024 * |
3.44% | Yield 2025 * |
3.72% | Free-Float | 99.75% |
Latest transcript on Amgen Inc.
1 day | +0.27% | ||
1 week | +0.25% | ||
Current month | -5.17% | ||
1 month | -4.32% | ||
3 months | -13.52% | ||
6 months | -0.04% | ||
Current year | -6.39% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 06-05-31 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 19-10-22 |
James Bradner
CTO | Chief Tech/Sci/R&D Officer | 52 | Dec. 17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 17-02-02 |
Ellen Kullman
BRD | Director/Board Member | 68 | 16-10-13 |
Robert Williams
BRD | Director/Board Member | 75 | 14-10-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 120 M€ | +12.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 269.5 | +0.04% | 503 386 |
24-04-25 | 269.4 | -1.33% | 1,794,024 |
24-04-24 | 273 | -0.19% | 2,467,127 |
24-04-23 | 273.5 | +0.60% | 2,493,321 |
24-04-22 | 271.9 | +1.11% | 2,165,755 |
Delayed Quote Nasdaq, April 26, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.39% | 144B | |
+26.11% | 653B | |
+27.00% | 556B | |
-6.45% | 354B | |
+20.45% | 331B | |
+3.29% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-11.86% | 143B |
- Stock Market
- Equities
- AMGN Stock